PGR and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is a therapeutically relevant definition of a subgroup of breast cancers (BCs) characterized by the absence of staining for the estrogen receptor (ER), the progesterone receptor (PR), and human epidermal factor receptor 2 (HER2).